Citation Impact
Citing Papers
Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma
2014 Standout
Maintenance Olaparib for Germline BRCA -Mutated Metastatic Pancreatic Cancer
2019
Experimental study on curcumin inhibiting proliferation and invasion of human osteosarcoma cells
2017
Pharmacological inhibition of Bcl-xL sensitizes osteosarcoma to doxorubicin
2015
Engineering precision nanoparticles for drug delivery
2020 Standout
Flavonoids as natural phenolic compounds and their role in therapeutics: an overview
2021 Standout
A randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecological cancers: Evaluating the impact on metabolic and inflammatory profiles and quality of life
2011
Pancreatic cancer
2020 Standout
Gestational trophoblastic disease
2010 Standout
Systemic inflammation, nutritional status and survival in patients with cancer
2009
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
2014 Standout
Osteosarcoma treatment – Where do we stand? A state of the art review
2013 Standout
Cancer-associated cachexia
2018 Standout
Inflammation-Based Prognostic Indices in Malignant Pleural Mesothelioma
2012
A novel and validated prognostic index in hepatocellular carcinoma: The inflammation based index (IBI)
2012
Glasgow Prognostic Score is a Predictor of Perioperative and Long-term Outcome in Patients with only Surgically Treated Esophageal Cancer
2010
Targeting apoptosis in cancer therapy
2020 Standout
Target delivery selective CSF-1R inhibitor to tumor-associated macrophages via erythrocyte-cancer cell hybrid membrane camouflaged pH-responsive copolymer micelle for cancer immunotherapy
2019
The Inflammation-Based Glasgow Prognostic ScorePredicts Survival in Patients With Cervical Cancer
2010
Significance of modified Glasgow prognostic score as a useful indicator for prognosis of patients with gastric carcinoma
2010
The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer
2013 Standout
Systemic inflammation and prediction of chemotherapy outcomes in patients receiving docetaxel for advanced cancer
2011
Inflammation-Based Prognostic Score and Number of Lymph Node Metastases Are Independent Prognostic Factors in Esophageal Squamous Cell Carcinoma
2010
Cancer-related inflammation and treatment effectiveness
2014 Standout
Systemic Inflammatory Response Predicts Prognosis in Patients with Advanced-Stage Colorectal Cancer
2008
Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature
2010 Standout
The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer
2012 Standout
Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline
2016
Mifamurtide in metastatic and recurrent osteosarcoma: A patient access study with pharmacokinetic, pharmacodynamic, and safety assessments
2013
Role of Systemic Inflammatory Response in Predicting Survival in Patients with Primary Operable Cancer
2009
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
2018 Standout
Natural product and natural product derived drugs in clinical trials
2014 Standout
mice: Multivariate Imputation by Chained Equations inR
2011 Standout
Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index
2013 Standout
Prognostic Significance of Host‐ and Tumor‐Related Factors in Patients with Gastric Cancer
2009
Molecular Origin of Blood‐Based Infrared Spectroscopic Fingerprints**
2021 StandoutNobel
Works of Jane Hook being referenced
Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
2015 Standout
Presence of chemotherapy-induced toxicity predicts improved survival in patients with localised extremity osteosarcoma treated with doxorubicin and cisplatin: A report from the European Osteosarcoma Intergroup
2011
Evaluation of an inflammation-based prognostic score in patients with advanced ovarian cancer
2008
The impact of molecular genetic diagnosis on the management of women with hCG-producing malignancies
2007
Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials
2011
Maintenance therapy in ovarian cancer
2014